Prognostic Value of T-Cell Density in the Tumor Center and Outer Margins in Gastric Cancer-Reference-Cited by-同舟云学术

Prognostic Value of T-Cell Density in the Tumor Center and Outer Margins in Gastric Cancer

Published:2023-09 Issue:9 Volume:36 Page:100218
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Modern Pathology

Author:

Soeratram Tanya T.D.^ORCID,Biesma Hedde D.,Egthuijsen Jacqueline M.P.,Meershoek-Klein Kranenbarg Elma,Hartgrink Henk H.,van de Velde Cornelis J.H.,Mookhoek Aart,van Dijk Erik,Kim Yongsoo,Ylstra Bauke,van Laarhoven Hanneke W.M.,van Grieken Nicole C.T.

Funder

KWF Kankerbestrijding

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference50 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

3. Heterogeneity in Gastric Cancer: From Pure Morphology to Molecular Classifications;Gullo;Pathobiology,2018

4. Comprehensive molecular characterization of gastric adenocarcinoma;Bass;Nature,2014

5. Pathohistological classification systems in gastric cancer: diagnostic relevance and prognostic value;Berlth;World J Gastroenterol,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infection with Epstein-Barr virus in gastric cancer patients and its impact on prognosis;World Chinese Journal of Digestology;2024-07-28

2. The tumor immune composition of mismatch repair deficient and Epstein-Barr virus-positive gastric cancer: A systematic review;Cancer Treatment Reviews;2024-06

3. Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software;Journal of Visualized Experiments;2024-04-12

4. Towards personalized management of early esophageal adenocarcinoma;Current Opinion in Gastroenterology;2024-04-11

5. First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study;Signal Transduction and Targeted Therapy;2024-03-25